# Hospital Regional Universitario de Málaga

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hospital-regional-universitario-de-malaga/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 60.3 |
| Citations | 317,622 |
| City | Málaga |
| Country | ES |
| Description | Hospital Regional Universitario de Málaga is a research organisation in Málaga, ES. OpenAlex records 9,020 works and 317,622 citations for it. 3,483 researchers list it as their most recent affiliation. |
| Homepage | http://www.hospitalregionaldemalaga.es/ |
| OpenAlex ID | https://openalex.org/I4210108548 |
| Researchers | 3,483 |
| ROR ID | https://ror.org/01mqsmm97 |
| Type | healthcare |
| Works | 9,020 |

## University papers

Showing 12 of 17.

- [Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial](https://scholariq.org/papers/erlotinib-versus-standard-chemotherapy-as-first-line-treatment-for-european/)
- [Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial](https://scholariq.org/papers/atezolizumab-versus-docetaxel-in-patients-with-previously-treated-non-small-cell/)
- [Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC](https://scholariq.org/papers/overall-survival-with-osimertinib-in-untreated-i-egfr-i-mutated-advanced-nsclc/)
- [Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study](https://scholariq.org/papers/amivantamab-plus-chemotherapy-with-and-without-lazertinib-in-egfr-mutant/)
- [A Gestational Profile of Placental Exosomes in Maternal Plasma and Their Effects on Endothelial Cell Migration](https://scholariq.org/papers/a-gestational-profile-of-placental-exosomes-in-maternal-plasma-and-their-effects/)
- [The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation](https://scholariq.org/papers/the-phenotypic-spectrum-of-organic-acidurias-and-urea-cycle-disorders-part-1-the/)
- [The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype](https://scholariq.org/papers/the-phenotypic-spectrum-of-organic-acidurias-and-urea-cycle-disorders-part-2-the/)
- [Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study](https://scholariq.org/papers/datopotamab-deruxtecan-versus-docetaxel-for-previously-treated-advanced-or/)
- [Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial](https://scholariq.org/papers/prebiotic-effect-during-the-first-year-of-life-in-healthy-infants-fed-formula/)
- [Phenotype, treatment practice and outcome in the cobalamin‐dependent remethylation disorders and MTHFR deficiency: Data from the E‐HOD registry](https://scholariq.org/papers/phenotype-treatment-practice-and-outcome-in-the-cobalamin-dependent/)
- [Food Protein‐induced Enterocolitis Syndrome](https://scholariq.org/papers/food-protein-induced-enterocolitis-syndrome/)
- [Molecular epidemiology, genotype–phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria](https://scholariq.org/papers/molecular-epidemiology-genotype-phenotype-correlation-and-bh4-responsiveness-in/)

## University researchers

- [Javier Blasco‐Alonso](https://scholariq.org/researchers/javier-blasco-alonso/)

## University top topics

Showing 8 of 25.

- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.